🧬 The past year has seen huge progress across MAGIC — from refining 3D muscle constructs to expanding engineered tissue and multi‑organoid platforms.
These advances are giving us more predictive ex vivo models and helping accelerate the path toward next‑gen gene therapies.
#MAGICProject
These advances are giving us more predictive ex vivo models and helping accelerate the path toward next‑gen gene therapies.
#MAGICProject
February 13, 2026 at 3:52 PM
🧬 The past year has seen huge progress across MAGIC — from refining 3D muscle constructs to expanding engineered tissue and multi‑organoid platforms.
These advances are giving us more predictive ex vivo models and helping accelerate the path toward next‑gen gene therapies.
#MAGICProject
These advances are giving us more predictive ex vivo models and helping accelerate the path toward next‑gen gene therapies.
#MAGICProject
Where is MAGIC? Across Europe and beyond.
Our consortium spans 10 countries, connecting leading institutions to tackle neuromuscular research challenges together.
🔗 magic-horizon.eu
#MAGICProject #ResearchCollaboration #NeuromuscularResearch
Our consortium spans 10 countries, connecting leading institutions to tackle neuromuscular research challenges together.
🔗 magic-horizon.eu
#MAGICProject #ResearchCollaboration #NeuromuscularResearch
January 22, 2026 at 12:13 PM
Where is MAGIC? Across Europe and beyond.
Our consortium spans 10 countries, connecting leading institutions to tackle neuromuscular research challenges together.
🔗 magic-horizon.eu
#MAGICProject #ResearchCollaboration #NeuromuscularResearch
Our consortium spans 10 countries, connecting leading institutions to tackle neuromuscular research challenges together.
🔗 magic-horizon.eu
#MAGICProject #ResearchCollaboration #NeuromuscularResearch
ICYMI: What’s next for neuromuscular treatment development?
MAGIC Project joined Muscular Dystrophy UK's Muscles Matter podcast to discuss SMA gene therapies, AI, and the future of collaborative research.
🎧 Listen: bit.ly/4aJpPodcast
#MAGICProject #GeneTherapy #Podcast
MAGIC Project joined Muscular Dystrophy UK's Muscles Matter podcast to discuss SMA gene therapies, AI, and the future of collaborative research.
🎧 Listen: bit.ly/4aJpPodcast
#MAGICProject #GeneTherapy #Podcast
January 15, 2026 at 9:15 AM
ICYMI: What’s next for neuromuscular treatment development?
MAGIC Project joined Muscular Dystrophy UK's Muscles Matter podcast to discuss SMA gene therapies, AI, and the future of collaborative research.
🎧 Listen: bit.ly/4aJpPodcast
#MAGICProject #GeneTherapy #Podcast
MAGIC Project joined Muscular Dystrophy UK's Muscles Matter podcast to discuss SMA gene therapies, AI, and the future of collaborative research.
🎧 Listen: bit.ly/4aJpPodcast
#MAGICProject #GeneTherapy #Podcast
🎆 Happy New Year from the MAGIC Project! 🎆
In 2026, we’ll keep pushing boundaries in neuromuscular research:
✅ Better disease models
✅ Gene therapy innovation
✅ Stronger networks for translation
Learn more: magic-horizon.eu
#MAGICProject #HappyNewYear
In 2026, we’ll keep pushing boundaries in neuromuscular research:
✅ Better disease models
✅ Gene therapy innovation
✅ Stronger networks for translation
Learn more: magic-horizon.eu
#MAGICProject #HappyNewYear
January 7, 2026 at 9:23 AM
🎆 Happy New Year from the MAGIC Project! 🎆
In 2026, we’ll keep pushing boundaries in neuromuscular research:
✅ Better disease models
✅ Gene therapy innovation
✅ Stronger networks for translation
Learn more: magic-horizon.eu
#MAGICProject #HappyNewYear
In 2026, we’ll keep pushing boundaries in neuromuscular research:
✅ Better disease models
✅ Gene therapy innovation
✅ Stronger networks for translation
Learn more: magic-horizon.eu
#MAGICProject #HappyNewYear
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
November 26, 2025 at 12:28 PM
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
🔬 Earlier this month at #ESGCT2025, MAGIC partners
@crick.ac.uk
shared 3 posters on human models for neuromuscular gene therapy:
🧪 3D cultures for DMD
🧠 AAV dynamics in multi-organoids
🧬 Myotubular myopathy modelling
Pushing boundaries in patient-relevant research.
#genetherapy #MagicProject
@crick.ac.uk
shared 3 posters on human models for neuromuscular gene therapy:
🧪 3D cultures for DMD
🧠 AAV dynamics in multi-organoids
🧬 Myotubular myopathy modelling
Pushing boundaries in patient-relevant research.
#genetherapy #MagicProject
October 22, 2025 at 8:30 AM
🔬 Earlier this month at #ESGCT2025, MAGIC partners
@crick.ac.uk
shared 3 posters on human models for neuromuscular gene therapy:
🧪 3D cultures for DMD
🧠 AAV dynamics in multi-organoids
🧬 Myotubular myopathy modelling
Pushing boundaries in patient-relevant research.
#genetherapy #MagicProject
@crick.ac.uk
shared 3 posters on human models for neuromuscular gene therapy:
🧪 3D cultures for DMD
🧠 AAV dynamics in multi-organoids
🧬 Myotubular myopathy modelling
Pushing boundaries in patient-relevant research.
#genetherapy #MagicProject
🔬 MAGIC at #ESGCT2025!
DINAMIQS shared how mass photometry boosts AAV packaging efficiency & stability.
📌 >95% full capsids = better stress resilience.
🚀 Fast, label-free AAV quality checks = smarter upstream optimisation.
#MAGICProject #GeneTherapy #AAV
DINAMIQS shared how mass photometry boosts AAV packaging efficiency & stability.
📌 >95% full capsids = better stress resilience.
🚀 Fast, label-free AAV quality checks = smarter upstream optimisation.
#MAGICProject #GeneTherapy #AAV
October 16, 2025 at 9:54 AM
🔬 MAGIC at #ESGCT2025!
DINAMIQS shared how mass photometry boosts AAV packaging efficiency & stability.
📌 >95% full capsids = better stress resilience.
🚀 Fast, label-free AAV quality checks = smarter upstream optimisation.
#MAGICProject #GeneTherapy #AAV
DINAMIQS shared how mass photometry boosts AAV packaging efficiency & stability.
📌 >95% full capsids = better stress resilience.
🚀 Fast, label-free AAV quality checks = smarter upstream optimisation.
#MAGICProject #GeneTherapy #AAV
CVE-2025-57203 - MagicProject AI Cross-Site Scripting (XSS) Vulnerability
CVE ID : CVE-2025-57203
Published : Sept. 22, 2025, 8:15 p.m. | 59 minutes ago
Description : MagicProject AI version 9.1 is affected by a Cross-Site Scripting (XSS) vulnerability within the chatbot...
CVE ID : CVE-2025-57203
Published : Sept. 22, 2025, 8:15 p.m. | 59 minutes ago
Description : MagicProject AI version 9.1 is affected by a Cross-Site Scripting (XSS) vulnerability within the chatbot...
CVE-2025-57203 - MagicProject AI Cross-Site Scripting (XSS) Vulnerability
MagicProject AI version 9.1 is affected by a Cross-Site Scripting (XSS) vulnerability within the chatbot generation feature available to authenticated admin users. The vulnerability resides in the prompt parameter submitted to the /dashboard/user/generator/generate-stream endpoint via a multipart/form-data POST request. Due to insufficient input sanitization, attackers can inject HTML-based JavaScript payloads. …
cvefeed.io
September 22, 2025 at 10:08 PM
CVE-2025-57203 - MagicProject AI Cross-Site Scripting (XSS) Vulnerability
CVE ID : CVE-2025-57203
Published : Sept. 22, 2025, 8:15 p.m. | 59 minutes ago
Description : MagicProject AI version 9.1 is affected by a Cross-Site Scripting (XSS) vulnerability within the chatbot...
CVE ID : CVE-2025-57203
Published : Sept. 22, 2025, 8:15 p.m. | 59 minutes ago
Description : MagicProject AI version 9.1 is affected by a Cross-Site Scripting (XSS) vulnerability within the chatbot...
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
August 27, 2025 at 8:47 AM
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
🚨 New publication from the #MAGICproject!
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
August 6, 2025 at 8:09 AM
🚨 New publication from the #MAGICproject!
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
📫 Our next newsletter is landing in inboxes soon!
Subscribe to hear about the latest developments from the #MAGICproject:
🔬 Genetic therapies advances for muscular dystrophies
📰 Conference & event highlights
📝 New research publications
…& more!
👉 magic-horizon.eu/news-events/...
Subscribe to hear about the latest developments from the #MAGICproject:
🔬 Genetic therapies advances for muscular dystrophies
📰 Conference & event highlights
📝 New research publications
…& more!
👉 magic-horizon.eu/news-events/...
July 24, 2025 at 9:36 AM
📫 Our next newsletter is landing in inboxes soon!
Subscribe to hear about the latest developments from the #MAGICproject:
🔬 Genetic therapies advances for muscular dystrophies
📰 Conference & event highlights
📝 New research publications
…& more!
👉 magic-horizon.eu/news-events/...
Subscribe to hear about the latest developments from the #MAGICproject:
🔬 Genetic therapies advances for muscular dystrophies
📰 Conference & event highlights
📝 New research publications
…& more!
👉 magic-horizon.eu/news-events/...
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
July 2, 2025 at 11:40 AM
🔬 Curious about the latest progress in gene therapy for muscular dystrophies?
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
The #MAGICproject is publishing impactful research, scientific tools & resources for the wider community.
🧬 Explore open-access papers, abstracts, and key findings here:
👉 magic-horizon.eu
#GeneTherapy #RareDisease
🚨 New pre-print from the #MAGICproject!
Our team modelled L-CMD, a severe laminopathy, using iPSC-derived skeletal muscle & showed how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
Our team modelled L-CMD, a severe laminopathy, using iPSC-derived skeletal muscle & showed how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
June 25, 2025 at 1:03 PM
🚨 New pre-print from the #MAGICproject!
Our team modelled L-CMD, a severe laminopathy, using iPSC-derived skeletal muscle & showed how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
Our team modelled L-CMD, a severe laminopathy, using iPSC-derived skeletal muscle & showed how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
🚨 New pre-print from the #MAGICproject!
We model L-CMD-a severe laminopathy-using iPSC-derived skeletal muscle & show how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
www.biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
We model L-CMD-a severe laminopathy-using iPSC-derived skeletal muscle & show how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
www.biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
June 24, 2025 at 9:04 AM
🚨 New pre-print from the #MAGICproject!
We model L-CMD-a severe laminopathy-using iPSC-derived skeletal muscle & show how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
www.biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
We model L-CMD-a severe laminopathy-using iPSC-derived skeletal muscle & show how precise CRISPR correction reverses nuclear defects, while exon-skipping doesn’t.
www.biorxiv.org/content/10.1...
#Laminopathy #GeneTherapy #iPSC
🔬 In the #MAGICproject, Prof. Karen English (@muresearch.bsky.social) is tackling immune reactions to AAV gene therapies for muscular dystrophy.
The goal: identify & calm early immune responses to boost safety & efficacy.
🔬 Full interview: magic-horizon.eu/news/meet-nu...
#GeneTherapy #AAV
The goal: identify & calm early immune responses to boost safety & efficacy.
🔬 Full interview: magic-horizon.eu/news/meet-nu...
#GeneTherapy #AAV
June 19, 2025 at 10:18 AM
🔬 In the #MAGICproject, Prof. Karen English (@muresearch.bsky.social) is tackling immune reactions to AAV gene therapies for muscular dystrophy.
The goal: identify & calm early immune responses to boost safety & efficacy.
🔬 Full interview: magic-horizon.eu/news/meet-nu...
#GeneTherapy #AAV
The goal: identify & calm early immune responses to boost safety & efficacy.
🔬 Full interview: magic-horizon.eu/news/meet-nu...
#GeneTherapy #AAV
🚨 New publication from the #MAGICproject!
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
June 11, 2025 at 11:06 AM
🚨 New publication from the #MAGICproject!
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
A novel iPSC line from a UCMD patient with a COL6A1 mutation offers a valuable new model for studying collagen VI-related muscular dystrophies and testing therapies.
📖 Read the paper: www.sciencedirect.com/science/arti...
📫 Our next newsletter is landing in inboxes soon!
Subscribe to hear the latest updates from the #MAGICproject, such as:
🔬 Advances in genetic therapies for muscular dystrophies
📰 Conference and event highlights
📝 New research publications
…and more!
👉 Sign up: magic-horizon.eu/news-events/...
Subscribe to hear the latest updates from the #MAGICproject, such as:
🔬 Advances in genetic therapies for muscular dystrophies
📰 Conference and event highlights
📝 New research publications
…and more!
👉 Sign up: magic-horizon.eu/news-events/...
May 29, 2025 at 2:10 PM
📫 Our next newsletter is landing in inboxes soon!
Subscribe to hear the latest updates from the #MAGICproject, such as:
🔬 Advances in genetic therapies for muscular dystrophies
📰 Conference and event highlights
📝 New research publications
…and more!
👉 Sign up: magic-horizon.eu/news-events/...
Subscribe to hear the latest updates from the #MAGICproject, such as:
🔬 Advances in genetic therapies for muscular dystrophies
📰 Conference and event highlights
📝 New research publications
…and more!
👉 Sign up: magic-horizon.eu/news-events/...
From discovery to delivery, gene therapies must be scalable.
Siegfried DINAMIQS supports the #MAGICproject to tackle manufacturing early.
Eduard Ayuso: “...make groundbreaking therapies manufacturable at quality and cost for patients.”
🔗 magic-horizon.eu/news/meet-di...
Siegfried DINAMIQS supports the #MAGICproject to tackle manufacturing early.
Eduard Ayuso: “...make groundbreaking therapies manufacturable at quality and cost for patients.”
🔗 magic-horizon.eu/news/meet-di...
May 22, 2025 at 8:12 AM
From discovery to delivery, gene therapies must be scalable.
Siegfried DINAMIQS supports the #MAGICproject to tackle manufacturing early.
Eduard Ayuso: “...make groundbreaking therapies manufacturable at quality and cost for patients.”
🔗 magic-horizon.eu/news/meet-di...
Siegfried DINAMIQS supports the #MAGICproject to tackle manufacturing early.
Eduard Ayuso: “...make groundbreaking therapies manufacturable at quality and cost for patients.”
🔗 magic-horizon.eu/news/meet-di...
Rare muscular dystrophies know no borders🌍
The #MAGICproject unites global researchers to develop genetic therapies.
Its now easier to learn about MAGIC's goals as our project leaflets are available in 6 languages!
Download 👉 magic-horizon.eu/media/leafle...
#MuscularDystrophy
The #MAGICproject unites global researchers to develop genetic therapies.
Its now easier to learn about MAGIC's goals as our project leaflets are available in 6 languages!
Download 👉 magic-horizon.eu/media/leafle...
#MuscularDystrophy
May 12, 2025 at 3:27 PM
Rare muscular dystrophies know no borders🌍
The #MAGICproject unites global researchers to develop genetic therapies.
Its now easier to learn about MAGIC's goals as our project leaflets are available in 6 languages!
Download 👉 magic-horizon.eu/media/leafle...
#MuscularDystrophy
The #MAGICproject unites global researchers to develop genetic therapies.
Its now easier to learn about MAGIC's goals as our project leaflets are available in 6 languages!
Download 👉 magic-horizon.eu/media/leafle...
#MuscularDystrophy
🔬 Meet the minds behind MAGIC! Dive into our partner interviews to see how global experts are uniting to revolutionize gene therapies for muscular dystrophies.
Discover their stories and insights here: magic-horizon.eu/news-events/...
#MAGICproject #GeneTherapy #MuscularDystrophy
Discover their stories and insights here: magic-horizon.eu/news-events/...
#MAGICproject #GeneTherapy #MuscularDystrophy
May 6, 2025 at 4:23 PM
🔬 Meet the minds behind MAGIC! Dive into our partner interviews to see how global experts are uniting to revolutionize gene therapies for muscular dystrophies.
Discover their stories and insights here: magic-horizon.eu/news-events/...
#MAGICproject #GeneTherapy #MuscularDystrophy
Discover their stories and insights here: magic-horizon.eu/news-events/...
#MAGICproject #GeneTherapy #MuscularDystrophy
💫 The #MAGICProject is developing transformative gene therapies for people living with rare muscular dystrophies - conditions that affect movement, eating, breathing & more.
🧬 With leading experts on board, we’re pushing research forward, faster.
🔗 magic-horizon.eu
🧬 With leading experts on board, we’re pushing research forward, faster.
🔗 magic-horizon.eu
May 2, 2025 at 3:55 PM
💫 The #MAGICProject is developing transformative gene therapies for people living with rare muscular dystrophies - conditions that affect movement, eating, breathing & more.
🧬 With leading experts on board, we’re pushing research forward, faster.
🔗 magic-horizon.eu
🧬 With leading experts on board, we’re pushing research forward, faster.
🔗 magic-horizon.eu